Last reviewed · How we verify
GSK679586
At a glance
| Generic name | GSK679586 |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma (PHASE2)
- A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSK679586 CI brief — competitive landscape report
- GSK679586 updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI